PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
10-May-2024 New EU directive will require UK businesses trading with the EU to enforce ESG compliance within their supply chains INVERTO
10-May-2024 Bloomsbury Genetic Therapies showcases its First Preclinical Data on Parkinson’s Disease Program at the American Society of Gene & Cell Therapy 2024 Annual Meeting Bloomsbury Genetic Therapies Limited
10-May-2024 Commit Biologics launches with €16m seed financing to pioneer complement system activation to treat cancer and autoimmune disease Commit Biologics
09-May-2024 EDWARDS LAUNCHES THE SAPIEN 3 ULTRA RESILIA VALVE WITH TECHNOLOGY TO ENHANCE DURABILITY Edwards Lifesciences
09-May-2024 PureTech Founded Entity Seaport Therapeutics Presents Data from Multiple SPT-300 Trials at Society of Biological Psychiatry (SOBP) Annual Meeting PureTech Health plc
09-May-2024 Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2024 Nxera Pharma
09-May-2024 New Report Reveals The Extent of Life Science Sector's Perfect Storm Medicines Discovery Catapult (MDC)
09-May-2024 Teva and Medincell Announce Positive Phase 3 Efficacy Results from SOLARIS Trial Evaluating TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable in Adults with Schizophrenia MedinCell
09-May-2024 HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee HUTCHMED
09-May-2024 ENA Respiratory Receives USPTO Notice of Allowance for Key Patent Covering INNA-051, a First-in-Class Antiviral Innate Immunomodulator ENA Respiratory
09-May-2024 DevPro Biopharma and Bespak Complete Early Feasibility Studies for New Groundbreaking Albuterol Inhaler DevPro Biopharma
08-May-2024 Free GCP Training from Pharma Lessons Pharma Lessons
07-May-2024 Jo Goodman Joins Celerion as Vice President of Bioanalytical Services Celerion
07-May-2024 PureTech Founded Entity Seaport Therapeutics Adds Industry Veteran to Board of Directors and Makes Key Executive Appointments PureTech Health plc
07-May-2024 Leica Microsystems adds cutting-edge light sheet solutions to its portfolio with the integration of Viventis Microscopy Leica Microsystems
07-May-2024 TMC welcomes Simon Estcourt as new Chief Executive Officer (CEO) to spearhead next phase of development TMC Pharma Services Ltd
07-May-2024 EyeDNA Therapeutics Announces Positive 24-month Data Presented at ARVO from Ongoing Phase I/II Trial of HORA-PDE6b Gene Therapy in Patients with Retinitis Pigmentosa Caused by Bi-allelic Mutations in PDE6b EyeDNA Therapeutics
07-May-2024 National approval for MOB-015 in all 13 countries Moberg Pharma AB
07-May-2024 Atopia Therapeutics, Formerly HpVac, Announces Appointment of Dr. Gregoire Chevalier as CEO and Business Update Atopia Therapeutics
03-May-2024 SynOx Therapeutics secures up to $35m debt financing with Hercules Capital to progress development and commercialisation of emactuzumab SynOx Therapeutics Limited